These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19016543)

  • 1. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.
    Burns TM; Conaway MR; Cutter GR; Sanders DB;
    Muscle Nerve; 2008 Dec; 38(6):1553-62. PubMed ID: 19016543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and shifts in distribution of muscle weakness in myasthenia gravis.
    de Meel RHP; Tannemaat MR; Verschuuren JJGM
    Neuromuscul Disord; 2019 Sep; 29(9):664-670. PubMed ID: 31488385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The otolaryngologic presentation of myasthenia gravis.
    Carpenter RJ; McDonald TJ; Howard FM
    Laryngoscope; 1979 Jun; 89(6 Pt 1):922-8. PubMed ID: 449537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of myasthenia gravis.
    Hopkins LC
    Neurol Clin; 1994 May; 12(2):243-61. PubMed ID: 8041340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients.
    Farrugia ME; Harle HD; Carmichael C; Burns TM
    Muscle Nerve; 2011 Mar; 43(3):329-34. PubMed ID: 21305562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myasthenia gravis--specific activities of daily living profile.
    Muppidi S
    Ann N Y Acad Sci; 2012 Dec; 1274():114-9. PubMed ID: 23252905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.
    Bedlack RS; Simel DL; Bosworth H; Samsa G; Tucker-Lipscomb B; Sanders DB
    Neurology; 2005 Jun; 64(11):1968-70. PubMed ID: 15955957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific measure of quality of life for myasthenia gravis.
    Mullins LL; Carpentier MY; Paul RH; Sanders DB;
    Muscle Nerve; 2008 Aug; 38(2):947-56. PubMed ID: 18697209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construct and concurrent validation of the MG-QOL15 in the practice setting.
    Burns TM; Grouse CK; Conaway MR; Sanders DB;
    Muscle Nerve; 2010 Feb; 41(2):219-26. PubMed ID: 19941339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.
    Burns TM; Conaway MR; Cutter GR; Sanders DB;
    Muscle Nerve; 2008 Aug; 38(2):957-63. PubMed ID: 18642357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dysphagia and dysarthria: unusual presentation of Myasthenia Gravis].
    Ferreira S; Lage P; Claro I; Alcântara J; Nunes J; Nobre Leitão C
    Acta Med Port; 2007; 20(5):463-6. PubMed ID: 18282445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the frontline: what an optometrist needs to know about myasthenia gravis.
    Pruitt JA; Ilsen PF
    Optometry; 2010 Sep; 81(9):454-60. PubMed ID: 20655284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental management of patients with myasthenia gravis: a literature review.
    Yarom N; Barnea E; Nissan J; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Aug; 100(2):158-63. PubMed ID: 16037773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile myasthenia gravis: three case reports and a literature review.
    Gadient P; Bolton J; Puri V
    J Child Neurol; 2009 May; 24(5):584-90. PubMed ID: 19406758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis.
    Burns TM; Grouse CK; Wolfe GI; Conaway MR; Sanders DB;
    Muscle Nerve; 2011 Jan; 43(1):14-8. PubMed ID: 21082698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reliability study of impairment and disability scales for myasthenia gravis patients.
    Romani A; Piccolo G; Bergamaschi R; Versino M; Cosi V
    Funct Neurol; 2002; 17(3):137-44. PubMed ID: 12549719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.
    Burns TM
    Ann N Y Acad Sci; 2012 Dec; 1274():99-106. PubMed ID: 23252903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements.
    Padua L; Evoli A; Aprile I; Caliandro P; Mazza S; Padua R; Tonali P
    Neurol Sci; 2001 Oct; 22(5):363-9. PubMed ID: 11917973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician- and self-assessed myasthenia gravis activities of daily living score.
    Lee HL; Min JH; Seok JM; Cho EB; Cho HJ; Kim YD; Kim BJ
    Muscle Nerve; 2018 Mar; 57(3):419-422. PubMed ID: 28796382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.